Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pain drug shows promise in tummy tuck recovery

NCT ID NCT06545097

First seen Jan 08, 2026 · Last updated May 23, 2026 · Updated 23 times

Summary

This study tested a new pain medication called cebranopadol in 279 people who had a tummy tuck (abdominoplasty). The goal was to see if it safely reduces moderate to severe pain after surgery compared to a placebo. Participants received either the drug or a dummy pill, and pain levels were measured over 48 hours.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • ALLEVIATE 1 Site 001106

    Little Rock, Arkansas, 72211, United States

  • ALLEVIATE 1 Site 001110

    Bellaire, Texas, 77401, United States

  • ALLEVIATE 1 Site 001111

    San Antonio, Texas, 78240, United States

  • ALLEVIATE 1 Site 001112

    Miami, Florida, 33014, United States

Conditions

Explore the condition pages connected to this study.